PAXVAX, INC.
REDWOOD CITY, CA · Founded 2006 · CIK 0001402296 · Biotech · Acquired
HIV-1 vaccine using recombinant simian adenovirus vectors expressing HIV envelope glycoproteins
paxvax.com →- Grants
- $2.8M
- 3 awards
- Sector median: 1
- Raised
- $58M
- 5 Form D · Apr 2014
- 150 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 0 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20092010201120122013201420152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $24,296,875 | |
| Private capital raised | Form D · SEC | $2,500,000 | |
| Private capital raised | Form D · SEC | $22,745,849 | |
| Private capital raised | Form D · SEC | $6,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · HIV B-Cell Lineage Vaccine Design Based on Replicating SAd and Env Protein in NHP | $801,463 | |
| Federal grant | Department of Defense · Phase II · Modernized Production of Enteric Coated Live, Oral Adenovirus Vaccine | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · HIV B-Cell Lineage Vaccine Design Based on Replicating SAd and Env Protein in NHP | $971,055 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1955 | KIBIO INC. | — | — |
| 1956 | SAROS THERAPEUTICS INC | — | — |
| 1957 | Base2 Genomics LLC | — | — |
| 1958 | PAXVAX, INC. | — | $58M |
| 1959 | Synbiotic Health, Inc. | — | $6.0M |
| 1960 | CelLink Corp | — | $25M |
| 1961 | Vanquish Bio LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Rennie CoitDirector
- Henry Coit, Jr.Director
- HENRY COIT, JR.Director
- James ConnollyDirector
- JAMES CONNOLLYDirector
- Kenneth KelleyDirector · Executive Officer
- KENNETH KELLEYDirector · Executive Officer
- Howard RosenDirector
- HOWARD ROSENDirector
- Phil RussellDirector
- PHIL RUSSELLDirector
- Janine TaylorExecutive Officer
- Richard TongDirector
- RICHARD TONGDirector
Patents
- Adenoviral-based Vectorsapplication
- Nanocoatings For Biological Materialsapplication
- Formulations Useful For Spray Drying Vaccinesapplication
- Adenoviral-based Vectorsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.